Benzinga | Nov 10, 2020 08:27AM EST

Ladenburg Thalmann Initiates Coverage On Tarsus Pharmaceuticals with Buy Rating, Announces Price Target of $42

Ladenburg Thalmann initiates coverage on Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy rating and announces Price Target of $42.